MEDBLUE PRINTS

MEDBLUE PRINTS is a multidisciplinary, peer-reviewed journal covering all fields of Medical Sciences with strong relevance to Life Sciences. We publish research that advances understanding of human health and disease, from fundamental molecular mechanisms to translational and clinical applications, across diverse biomedical disciplines.

The journal is launched by the Professionals of Novel Academy of Science (United Kingdom) in collaboration with Medical Blueprints Publishers, with the mission to support credible scientific communication, research integrity, and global academic exchange.

What we publish

We welcome scientifically robust and ethically conducted manuscripts including:

• Original Research Articles

• Review Articles

• Systematic Reviews and Meta-Analyses

• Short Communications

• Case-based Scientific Reports (where methodologically appropriate)

• Methodology / Technical Notes

• Brief Reports and Research Letters

• Editorials and Perspectives (commissioned or invited)

Why MEDBLUE PRINTS

At MEDBLUE PRINTS, we aim to provide:

• Rigorous peer review with clear editorial decisions

• Transparent policies aligned with internationally recognized publication ethics guidance

• A broad scope that enables interdisciplinary visibility across medical and life sciences

• A scholarly platform for authors from academia, hospitals, research institutes, and industry

Explore our scope

MEDBLUE PRINTS covers a wide spectrum of topics including molecular biology, oncology, immunology, infectious diseases, pharmacology, pathology, laboratory medicine, biotechnology, public health, epidemiology, clinical research, and allied health sciences. Our goal is to publish work that is both scientifically meaningful and clinically or biologically relevant.

2) About MEDBLUE PRINTS

MEDBLUE PRINTS is an academic journal dedicated to the dissemination of high-quality scholarship across Medical Sciences and Life Sciences. The journal serves as a platform for researchers, clinicians, laboratory professionals, and educators to communicate discoveries that improve scientific understanding and health outcomes.

Vision

Our vision is to develop MEDBLUE PRINTS into a trusted destination for multidisciplinary biomedical research by prioritizing:

• Methodological rigor and reproducibility

• Ethical publishing practices

• Scientific clarity and transparent reporting

• Relevance to healthcare, disease biology, diagnostics, and therapeutics

Mission

The mission of MEDBLUE PRINTS is to:

1. publish quality research with clear contribution to the field,

2. support fair and responsible peer review, and

3. provide an accessible academic venue for interdisciplinary biomedical work.

3) Aims & Scope

Aims

MEDBLUE PRINTS aims to publish peer-reviewed work that advances knowledge across all fields of Medical Sciences, particularly research that bridges medicine with Life Sciences, including molecular and translational approaches. We prioritize manuscripts that provide:

• Clear scientific novelty or meaningful confirmation of important findings

• Robust methods and appropriate statistics

• Ethical approvals and transparent reporting

• Practical relevance to disease mechanisms, diagnostics, prevention, or therapy

Scope

MEDBLUE PRINTS welcomes submissions from basic, translational, and clinical domains. We publish research spanning biological mechanisms, laboratory investigations, clinical observations, and population-level studies. We encourage interdisciplinary manuscripts that connect molecular pathways to disease outcomes, therapeutic innovation, or diagnostic development.

Covered disciplines include (not limited to)

Life Sciences and Molecular Medicine: molecular biology, genetics, genomics, proteomics, metabolomics, epigenetics, cell biology, microbiology, virology, immunology, inflammatory signaling, biomarker discovery.

Oncology and Cancer Biology: tumor biology, cancer immunology, molecular oncology, metastasis, tumor microenvironment, targeted therapeutics, experimental therapeutics, diagnostic markers, translational cancer research.

Clinical and Translational Research: clinical studies, clinical laboratory science, translational medicine, diagnostic evaluation, clinical pharmacology, treatment response, comorbidities, hospital-based research.

Pharmacology and Therapeutics: drug mechanisms, experimental pharmacology, toxicology, natural products research (with strong methodological quality), therapeutic targets, drug screening and validation.

Pathology and Laboratory Medicine: histopathology and molecular pathology, clinical biochemistry, hematology, microbiology diagnostics, quality systems, laboratory innovations.

Public Health and Epidemiology: population health, disease burden research, surveillance, prevention strategies, health systems, statistical modeling, community-based studies.

Allied Health Sciences: rehabilitation sciences, medical laboratory technology, nursing-related research, health education and evidence-based practice.